Published on
May 29, 2026
- 19:43 GMT
Genesee BioMedical Receives FDA 510(k) Clearance for ATLAAS™ Epicardial Left Atrial Appendage Occlusion Device
Second FDA clearance in less than two years reflects Genesee BioMedical’s design, manufacturing, regulatory expertise, & commitment to advancing cardiac surgery DENVER, CO, UNITED STATES, May 29, 2026 /EINPresswire.com/ -- Genesee BioMedical, Inc …
Distribution channels:
Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry
...
